Meng Z, Li J, Wang H, Cao Z, Lu W, Niu X
Biomark Res. 2025; 13(1):44.
PMID: 40087771
DOI: 10.1186/s40364-025-00756-4.
Suoangbaji T, Long R, Ng I, Mak L, Ho D
Cancers (Basel). 2025; 17(5).
PMID: 40075736
PMC: 11898674.
DOI: 10.3390/cancers17050890.
Zhang P, Gao C, Zhang Z, Yuan Z, Zhang Q, Zhang P
Nat Commun. 2025; 16(1):1838.
PMID: 39984438
PMC: 11845739.
DOI: 10.1038/s41467-025-57072-6.
Liu Y, Dong G, Yu J, Liang P
J Transl Med. 2025; 23(1):198.
PMID: 39966876
PMC: 11837652.
DOI: 10.1186/s12967-025-06192-0.
Liu R, Ye J, Wang J, Ma W, Qiu Z, Yu J
Sci Rep. 2025; 15(1):4130.
PMID: 39900964
PMC: 11791069.
DOI: 10.1038/s41598-025-88377-7.
Computational discovery of co-expressed antigens as dual targeting candidates for cancer therapy through bulk, single-cell, and spatial transcriptomics.
Chekalin E, Paithankar S, Shankar R, Xing J, Xu W, Chen B
Bioinform Adv. 2025; 4(1):vbae096.
PMID: 39872360
PMC: 11770384.
DOI: 10.1093/bioadv/vbae096.
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma.
Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B
Cell Discov. 2025; 11(1):1.
PMID: 39870619
PMC: 11772884.
DOI: 10.1038/s41421-024-00747-z.
Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrent tumor lesions.
Liu S, Feng C, Tan L, Zhang D, Li Y, Han Y
Commun Biol. 2024; 7(1):1659.
PMID: 39702554
PMC: 11659313.
DOI: 10.1038/s42003-024-07343-7.
Unraveling the Heterogeneity of Tumor Immune Microenvironment in Hepatocellular Carcinoma by SingleCell RNA Sequencing and its Implications for Prognosis and Therapeutic Response.
Han Y, Song L, Lv L, Fan C, Ding H
Turk J Gastroenterol. 2024; 35(12):876-888.
PMID: 39641225
PMC: 11639598.
DOI: 10.5152/tjg.2024.24118.
Zinc finger protein 296 promotes hepatocellular carcinoma progression via intervening interaction between macrophages and B cells.
Xu N, Xiang X, Chen H, Chen Y, Wang S, Guo H
Chin J Cancer Res. 2024; 36(5):517-529.
PMID: 39539816
PMC: 11555204.
DOI: 10.21147/j.issn.1000-9604.2024.05.05.
Genetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma.
Putatunda V, Jusakul A, Roberts L, Wang X
Am J Pathol. 2024; 195(3):362-377.
PMID: 39532242
PMC: 11841490.
DOI: 10.1016/j.ajpath.2024.10.013.
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Park R, Parikh M, Pappas L, Sade-Feldman M, Kulkarni A, Bi L
medRxiv. 2024; .
PMID: 39417106
PMC: 11483019.
DOI: 10.1101/2024.10.08.24315092.
Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
Li M, Xu T, Yang R, Wang X, Zhang J, Wu S
BMC Cancer. 2024; 24(1):1258.
PMID: 39390460
PMC: 11465577.
DOI: 10.1186/s12885-024-12622-x.
Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.
Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T
J Transl Med. 2024; 22(1):900.
PMID: 39367493
PMC: 11452965.
DOI: 10.1186/s12967-024-05685-8.
Analysis of the implication of steroid 5 alpha-reductase 3 on prognosis and immune microenvironment in Liver Hepatocellular Carcinoma.
Lu Y, Liu Z, Zheng Y, Liu X, Liu X, Chen N
Ann Med. 2024; 56(1):2408463.
PMID: 39340288
PMC: 11441025.
DOI: 10.1080/07853890.2024.2408463.
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactions.
Lu C, Pankaj A, Raabe M, Nawrocki C, Liu A, Xu N
Hepatol Commun. 2024; 8(10).
PMID: 39330965
PMC: 11441860.
DOI: 10.1097/HC9.0000000000000533.
Primary liver cancer organoids and their application to research and therapy.
Zhu X, Trehan R, Xie C
J Natl Cancer Cent. 2024; 4(3):195-202.
PMID: 39281720
PMC: 11401492.
DOI: 10.1016/j.jncc.2024.06.002.
Single-cell transcriptomics reveals tumor microenvironment remodeling in hepatocellular carcinoma with varying tumor subclonal complexity.
Shi J, Zhang Y, Xu L, Wang F
Front Genet. 2024; 15:1467682.
PMID: 39268081
PMC: 11390501.
DOI: 10.3389/fgene.2024.1467682.
Innovative aspects and applications of single cell technology for different diseases.
Ali A, Manzoor S, Ali T, Asim M, Muhammad G, Ahmad A
Am J Cancer Res. 2024; 14(8):4028-4048.
PMID: 39267684
PMC: 11387862.
DOI: 10.62347/VUFU1836.
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti-Tumor by Blocking Metabolic Interactions in Organoids.
Liu X, Wang C, Huang Y, Lv Q, Yu C, Ying J
Adv Sci (Weinh). 2024; 11(42):e2406653.
PMID: 39258580
PMC: 11558144.
DOI: 10.1002/advs.202406653.